findmyKOL

Roland Walter, MD

Enriched profile

Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center · Fred Hutchinson Cancer Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Seattle, WA · West · United StatesSpecialtyHematologyFocusAcute Myeloid Leukemia Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2009–2026

Roland Walter is Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center at Fred Hutchinson Cancer Center. OpenAlex indexes 700 publications with 20,655 citations (h-index 70); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Roland Walter, MD PHD, is Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center. The public record shows 700 publications with 20,655 citations (h-index 70), centered on Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Hematopoietic Stem Cell Transplantation. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 9 companies, 14 NIH-funded awards (2009–2026).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Acute Myeloid Leukemia Research
  • 12 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)12 trialsLeukemia, Myeloid, Acute9 trialsMDS / MPN5 trialsLeukemia, Erythroblastic, Acute4 trialsLeukemia, Biphenotypic, Acute2 trials

Research focus

OpenAlex concept fingerprint
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments

Drugs & molecules

across trials, industry payments and publications
Venclextageneric · VenetoclaxClinical trials—Industry payments1Publications2Xospatageneric · GilteritinibClinical trials—Industry payments4Publications—Revuforjgeneric · RevumenibClinical trials—Industry payments3Publications—Onureggeneric · AzacitidineClinical trials—Industry payments2Publications—Vyxeosgeneric · Cytarabine / daunorubicinClinical trials—Industry payments2Publications—Elzonrisgeneric · TagraxofuspClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments10Fred Hutchinson Cancer CenterClinical trials9Industry payments—GlaxoSmithKline, LLC.Clinical trials—Industry payments7Astellas Pharma US IncClinical trials—Industry payments4E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Syndax Pharmaceuticals, Inc.Clinical trials—Industry payments3Celgene CorporationClinical trials—Industry payments2Janssen Global Services, LLCClinical trials—Industry payments2Jazz Pharmaceuticals Inc.Clinical trials—Industry payments2Children's Oncology GroupClinical trials1Industry payments—National Cancer Institute (NCI)Clinical trials1Industry payments—Stemline Therapeutics Inc.Clinical trials—Industry payments1SWOG Cancer Research NetworkClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
700publications

Distinct works indexed by OpenAlex, matched via ORCID; 97 in PubMed.

20,655citations

Total citations across indexed works.

70h-index

Hirsch index (OpenAlex). i10-index 278.

Clinical & industry

trials, payments and federal funding
12clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
14NIH grants · 2009–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:

All 12 trial records: search, sort and filter.Explore →

Industry payments

Updated 18 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 17 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 18 Oct 2026

14 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:

All 44 award records: search, sort and filter.Explore →

Congress activity

Updated 18 Oct 2026

135 congress contributions (2005–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:

All 135 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 97 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
    Article1,043 citations2018
    doi.org ↗
  2. 02
    2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
    Article764 citations2021
    doi.org ↗
  3. 03
    Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
    Article690 citations2019
    doi.org ↗
  4. 04
    Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
    Article675 citations2020
    doi.org ↗
  5. 05
    A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
    Article638 citations2013
    doi.org ↗
All 700 cited works: search, sort and filter.Explore →

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Elihu H. Estey187Megan K. D. Othus170Anna B. Halpern112Frederick R. Appelbaum100Paul C. Hendrie99Mary‐Elizabeth M. Percival94Pamela Sue Becker91Harry Paul Erba62George S. Laszlo57Bart Lee Scott54Brent Lee Wood51Sarah A. Buckley50Brenda M. Sandmaier49Hagop M. Kantarjian48Carole M. Shaw45Eunice S. Wang44Farhad Ravandi43Kelda M. Gardner40Jacob Appelbaum37Ryan Daniel Cassaday37Pau Montesinos36John M. Pagel36Soheil Meshinchi35Chelsea J. Gudgeon35Vivian G. Oehler34Kimberly H. Harrington34Janis L. Abkowitz30Eduardo Rodriguez Arboli30Daniel J. DeAngelo30Susana Catalina Raimondi27Naval Guastad Daver27Betsy A Hirsch27Stefan H Faderl27Todd A. Alonzo27Anjali S. Advani27Colin D. Godwin27Gail J. Roboz26Alan S. Gamis26Irwin D. Bernstein25Filippo Milano25

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/roland-walter-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    fredhutch.org/en/news/center-news/2023/07/roland-walter-and-mazyar-shadman-receive-endowed-chairs.html

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certification in Hematology

    American Board of Internal Medicine

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Board Certification in Internal Medicine

    American Board of Internal Medicine

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • MS in Epidemiology and Clinical Research

    University of Washington

    2011
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
  • PhD

    University of Washington

    2006
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
  • MD

    Faculty of Medicine, University of Zürich

    1997
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor

    Division of Hematology and Oncology, University of Washington School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Adjunct Professor

    Department of Laboratory Medicine & Pathology, University of Washington

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Affiliate Investigator

    Clinical Research Division, Fred Hutchinson Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Member

    Immunotherapy Integrated Research Center (IIRC), Fred Hutchinson Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗

Media & interviews

press, podcasts and appearances
  • Speaker

    'Spotlight on Acute Myeloid Leukemia (AML)' webcast, Leukemia & Lymphoma Society and Blood Cancer United

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerunited.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.